Skip to main content

Table 2 Multivariate analysis of the predictive factors of KDIGO stage 2–3 acute kidney injury in patients with severe rhabdomyolysis

From: Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients

 Model 1
[AUC 0.81]
[Hosmer–Lemeshow test 0.31]
Model 2
[AUC 0.82]
[Hosmer–Lemeshow test 0.51]
Hazard ratio [IC5–95%]p valueHazard ratio [IC5–95%]p value
Serum phosphorus (per mmol/L)2.2 [1.6–4.9]0.00042.8 [1.4–5.6]0.003
Serum calcium (per mmol/L)2.37 [0.7–8.3]0.18
Myoglobin (> 8000 U/L at admission)2.03 [1.01–4.1]0.02
Creatine phosphokinase (per 1000 UI/L)1.01 [0.99–1.03]0.09
Serum potassium (per mmol/L)1.5 [1.1–2.0]0.021.7 [1.2–2.4]0.003
Bicarbonates (mmol/L)0.92 [0.86–0.99]0.030.95 [0.88–1.02]0.18
Vasoactive drugs1.9 [0.8–4.3]0.121.8 [0.8–4.1]0.16
Mechanical ventilation2.4 [1.05–5.5]0.041.9 [0.8–4.6]0.12
Prothrombin time (%)0.99 [0.97–1.01]0.20